59 related articles for article (PubMed ID: 8185342)
1. [Oral administration of low-dose etoposide for maintenance chemotherapy in adult T cell leukemia patients].
Utsunomiya A; Takatsuka Y; Takeshita T; Makino T; Ishitsuka K; Shimotakahara S; Ohno N; Kuwazuru Y; Uozumi K; Saito T
Gan To Kagaku Ryoho; 1994 May; 21(6):839-44. PubMed ID: 8185342
[TBL] [Abstract][Full Text] [Related]
2. [Long-term oral administration of etoposide (VP-16) for the patients with refractory or relapsed acute non-lymphocytic leukemia].
Koyama S; Saitou H; Kashiwaba M
Rinsho Ketsueki; 1991 Jul; 32(7):736-42. PubMed ID: 1920837
[TBL] [Abstract][Full Text] [Related]
3. [Utility of daily oral administration of etoposide in 25 cases of refractory hematological malignancies].
Kuga T; Kohda K; Matsumoto S; Nakazawa O; Ezoe A; Nobuoka A; Mochizuki C; Niitsu Y; Watanabe N
Gan To Kagaku Ryoho; 1997 Feb; 24(3):315-21. PubMed ID: 9051134
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
[TBL] [Abstract][Full Text] [Related]
5. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
6. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol.
Martino R; Guardia R; Altés A; Sureda A; Brunet S; Sierra J
Haematologica; 1999 Mar; 84(3):226-30. PubMed ID: 10189387
[TBL] [Abstract][Full Text] [Related]
7. [Successful chronic daily administration of oral etoposide for a case of adult T cell leukemia].
Matsuoka H; Toyama T; Horinouchi M; Maeda K; Suzuki M; Kubuki Y; Komura K; Ishikawa T; Uno H; Tsubouchi H
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1387-90. PubMed ID: 8346938
[TBL] [Abstract][Full Text] [Related]
8. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
9. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
[TBL] [Abstract][Full Text] [Related]
10. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.
Al Bahar S; Pandita R; Bavishi K; Kreze O
Indian J Cancer; 2004; 41(3):125-8. PubMed ID: 15472411
[TBL] [Abstract][Full Text] [Related]
11. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
[TBL] [Abstract][Full Text] [Related]
12. [Two cases of adult T-cell leukemia . lymphoma (ATL) with long-term remission by chronic daily administration of low-dose etoposide].
Ezoe A; Kohda K; Hirayama Y; Nobuoka A; Matsumoto S; Nakazawa O; Takahashi H; Muramatsu H; Matsunaga T; Watanabe N
Gan To Kagaku Ryoho; 1995 Mar; 22(4):547-52. PubMed ID: 7887647
[TBL] [Abstract][Full Text] [Related]
13. [Prolonged oral etoposide therapy in advanced stage lung cancer].
Bozóky G; Ruby E; Góhér I; Mohos A; Lengyel M
Orv Hetil; 1997 Jul; 138(28):1791-5. PubMed ID: 9280873
[TBL] [Abstract][Full Text] [Related]
14. [Combined chemotherapy after prolonged oral etoposide maintenance therapy in patients with small-cell lung cancer].
Bozóky G; Ruby E; Góhér I; Mohos A
Orv Hetil; 2000 Sep; 141(37):2035-8. PubMed ID: 11037613
[TBL] [Abstract][Full Text] [Related]
15. [Adult T cell leukemia/lymphoma effectively treated with chronic oral etoposide].
Yamane T; Ohta K; Nakao Y; Yasui Y; Shindo K; Tanaka K; Hasuike T; Hirai M; Takekawa K; Hirai N
Gan To Kagaku Ryoho; 1993 Sep; 20(12):1853-6. PubMed ID: 8379679
[TBL] [Abstract][Full Text] [Related]
16. [Oral etoposide therapy in stage III-IV ovarian carcinoma].
Takeda S; Takada S; Kojima T; Kinoshita K; Sakamoto S
Nihon Gan Chiryo Gakkai Shi; 1990 Oct; 25(10):2562-6. PubMed ID: 2262736
[TBL] [Abstract][Full Text] [Related]
17. Oral etoposide for recurrent/progressive sarcomas of childhood.
Kebudi R; Görgün O; Ayan I
Pediatr Blood Cancer; 2004 Apr; 42(4):320-4. PubMed ID: 14966827
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of amsacrine plus intermediate-dose Ara-C (IDAC) with or without etoposide as salvage therapy for refractory or relapsed acute leukemia.
Sung WJ; Kim DH; Sohn SK; Kim JG; Baek JH; Jeon SB; Moon JH; Ahn BM; Lee KB
Jpn J Clin Oncol; 2005 Oct; 35(10):612-6. PubMed ID: 16172175
[TBL] [Abstract][Full Text] [Related]
19. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
20. Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot study.
Tallman MS; Lee S; Sikic BI; Paietta E; Wiernik PH; Bennett JM; Rowe JM
Cancer; 1999 Jan; 85(2):358-67. PubMed ID: 10023703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
